Science and Development Network
News, views and information about science, technology and the developing world
A rising generics industry in developing nations is helping secure access to cheap drugs for the world's poor. But controversies over patent rules could divert investment from already neglected diseases.
(Photo credit: WHO/TDR/Crump)
Risk-averse researchers put mothers' lives at risk
Researchers are putting women's lives at risk by being too cautious about trialling drugs during pregnancy, say Nicholas J. White and colleagues.
Research deficiencies 'delaying HIV prevention'
Weaknesses in HIV research design have hindered progress in identifying prevention strategies, say Stephen W. Lagakos and Alicia R. Gable.
16 April 2008
|
EN
|
中文
Source: New England Journal of Medicine
29 February 2008
|
EN
|
ES
|
中文
Source: PLoS Neglected Tropical Diseases
Sickle cell drug mired in controversy
Production of a herbal-based sickle cell anaemia drug could be under threat as the companies involved are surrounded by allegations of corruption.
Peru is distributing a powder serum to tackle snakebites in remote areas of the country, and hopes to be the leaders of such research in the Andean region.
24 June 2008
|
ES
12 June 2008
|
EN